Global Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2023

Report ID: 1995846 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Chronic Idiopathic Constipation (CIC) Drugs Market Overview
    1.1 Product Overview and Scope of Chronic Idiopathic Constipation (CIC) Drugs
    1.2 Chronic Idiopathic Constipation (CIC) Drugs Segment by Type
        1.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Type (2023-2029)
        1.2.2 Lubiprostone
        1.2.3 Linaclotide
        1.2.4 Others
    1.3 Chronic Idiopathic Constipation (CIC) Drugs Segment by Application
        1.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Value by Application: (2023-2029)
        1.3.2 Hospitals & Clinics
        1.3.3 Ambulatory Surgical Centres
        1.3.4 Long Term Care Centres
        1.3.5 Others
    1.4 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Estimates and Forecasts
        1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2018-2029
        1.4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2018-2029
        1.4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Chronic Idiopathic Constipation (CIC) Drugs Market Competition by Manufacturers
    2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Average Price by Manufacturers (2018-2023)
    2.4 Global Chronic Idiopathic Constipation (CIC) Drugs Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Product Type & Application
    2.7 Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Situation and Trends
        2.7.1 Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue
        2.7.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario by Region
    3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2018-2029
        3.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2018-2023
        3.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region: 2024-2029
    3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2018-2029
        3.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2018-2023
        3.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2024-2029
    3.4 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country
        3.4.1 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2029)
        3.4.3 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country
        3.5.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2029)
        3.5.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country
        3.6.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2029)
        3.6.3 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country
        3.7.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2029)
        3.7.3 Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country
        3.8.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E
4 Segment by Type
    4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2018-2029)
        4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2018-2023)
        4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2024-2029)
        4.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2018-2029)
    4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2018-2029)
        4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2018-2023)
        4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2024-2029)
        4.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2018-2029)
    4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2018-2029)
5 Segment by Application
    5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2018-2029)
        5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2018-2023)
        5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2024-2029)
        5.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2018-2029)
    5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2018-2029)
        5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2018-2023)
        5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2024-2029)
        5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2018-2029)
    5.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2018-2029)
6 Key Companies Profiled
    6.1 Actavis
        6.1.1 Actavis Corporation Information
        6.1.2 Actavis Description and Business Overview
        6.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.1.5 Actavis Recent Developments/Updates
    6.2 Chugai Pharmaceutical
        6.2.1 Chugai Pharmaceutical Corporation Information
        6.2.2 Chugai Pharmaceutical Description and Business Overview
        6.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.2.5 Chugai Pharmaceutical Recent Developments/Updates
    6.3 Ferring International Center
        6.3.1 Ferring International Center Corporation Information
        6.3.2 Ferring International Center Description and Business Overview
        6.3.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.3.5 Ferring International Center Recent Developments/Updates
    6.4 Synergy Pharmaceuticals
        6.4.1 Synergy Pharmaceuticals Corporation Information
        6.4.2 Synergy Pharmaceuticals Description and Business Overview
        6.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.4.5 Synergy Pharmaceuticals Recent Developments/Updates
    6.5 Pfizer
        6.5.1 Pfizer Corporation Information
        6.5.2 Pfizer Description and Business Overview
        6.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.5.5 Pfizer Recent Developments/Updates
    6.6 GlaxoSmithKline
        6.6.1 GlaxoSmithKline Corporation Information
        6.6.2 GlaxoSmithKline Description and Business Overview
        6.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.6.5 GlaxoSmithKline Recent Developments/Updates
    6.7 Roche Holding
        6.6.1 Roche Holding Corporation Information
        6.6.2 Roche Holding Description and Business Overview
        6.6.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.7.5 Roche Holding Recent Developments/Updates
    6.8 Sanofi
        6.8.1 Sanofi Corporation Information
        6.8.2 Sanofi Description and Business Overview
        6.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.8.5 Sanofi Recent Developments/Updates
    6.9 Bayer
        6.9.1 Bayer Corporation Information
        6.9.2 Bayer Description and Business Overview
        6.9.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.9.5 Bayer Recent Developments/Updates
    6.10 Salix Pharmaceuticals
        6.10.1 Salix Pharmaceuticals Corporation Information
        6.10.2 Salix Pharmaceuticals Description and Business Overview
        6.10.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.10.5 Salix Pharmaceuticals Recent Developments/Updates
    6.11 Sucampo Pharmaceuticals
        6.11.1 Sucampo Pharmaceuticals Corporation Information
        6.11.2 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Description and Business Overview
        6.11.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.11.5 Sucampo Pharmaceuticals Recent Developments/Updates
    6.12 Ironwood Pharmaceuticals
        6.12.1 Ironwood Pharmaceuticals Corporation Information
        6.12.2 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Description and Business Overview
        6.12.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.12.5 Ironwood Pharmaceuticals Recent Developments/Updates
    6.13 Progenics Pharmaceuticals
        6.13.1 Progenics Pharmaceuticals Corporation Information
        6.13.2 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Description and Business Overview
        6.13.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product Portfolio
        6.13.5 Progenics Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Chain Analysis
    7.2 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Chronic Idiopathic Constipation (CIC) Drugs Production Mode & Process
    7.4 Chronic Idiopathic Constipation (CIC) Drugs Sales and Marketing
        7.4.1 Chronic Idiopathic Constipation (CIC) Drugs Sales Channels
        7.4.2 Chronic Idiopathic Constipation (CIC) Drugs Distributors
    7.5 Chronic Idiopathic Constipation (CIC) Drugs Customers
8 Chronic Idiopathic Constipation (CIC) Drugs Market Dynamics
    8.1 Chronic Idiopathic Constipation (CIC) Drugs Industry Trends
    8.2 Chronic Idiopathic Constipation (CIC) Drugs Market Drivers
    8.3 Chronic Idiopathic Constipation (CIC) Drugs Market Challenges
    8.4 Chronic Idiopathic Constipation (CIC) Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer
List of Tables
    Table 1. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Chronic Idiopathic Constipation (CIC) Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Chronic Idiopathic Constipation (CIC) Drugs, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Chronic Idiopathic Constipation (CIC) Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation (CIC) Drugs as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2018-2023) & (K Units)
    Table 18. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2018-2023)
    Table 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2024-2029) & (K Units)
    Table 20. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2024-2029)
    Table 21. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2018-2023)
    Table 23. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2024-2029)
    Table 25. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2023) & (K Units)
    Table 27. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2024-2029) & (K Units)
    Table 28. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Type (2018-2023)
    Table 51. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Type (2024-2029)
    Table 52. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2018-2023)
    Table 53. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2024-2029)
    Table 54. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2018-2023)
    Table 57. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2024-2029)
    Table 58. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Application (2018-2023)
    Table 61. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Application (2024-2029)
    Table 62. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2018-2023)
    Table 63. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2024-2029)
    Table 64. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2018-2023)
    Table 67. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2024-2029)
    Table 68. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Application (2024-2029)
    Table 70. Actavis Corporation Information
    Table 71. Actavis Description and Business Overview
    Table 72. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 74. Actavis Recent Developments/Updates
    Table 75. Chugai Pharmaceutical Corporation Information
    Table 76. Chugai Pharmaceutical Description and Business Overview
    Table 77. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 79. Chugai Pharmaceutical Recent Developments/Updates
    Table 80. Ferring International Center Corporation Information
    Table 81. Ferring International Center Description and Business Overview
    Table 82. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 84. Ferring International Center Recent Developments/Updates
    Table 85. Synergy Pharmaceuticals Corporation Information
    Table 86. Synergy Pharmaceuticals Description and Business Overview
    Table 87. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 89. Synergy Pharmaceuticals Recent Developments/Updates
    Table 90. Pfizer Corporation Information
    Table 91. Pfizer Description and Business Overview
    Table 92. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 94. Pfizer Recent Developments/Updates
    Table 95. GlaxoSmithKline Corporation Information
    Table 96. GlaxoSmithKline Description and Business Overview
    Table 97. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 99. GlaxoSmithKline Recent Developments/Updates
    Table 100. Roche Holding Corporation Information
    Table 101. Roche Holding Description and Business Overview
    Table 102. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 104. Roche Holding Recent Developments/Updates
    Table 105. Sanofi Corporation Information
    Table 106. Sanofi Description and Business Overview
    Table 107. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 109. Sanofi Recent Developments/Updates
    Table 110. Bayer Corporation Information
    Table 111. Bayer Description and Business Overview
    Table 112. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Bayer Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 114. Bayer Recent Developments/Updates
    Table 115. Salix Pharmaceuticals Corporation Information
    Table 116. Salix Pharmaceuticals Description and Business Overview
    Table 117. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 119. Salix Pharmaceuticals Recent Developments/Updates
    Table 120. Sucampo Pharmaceuticals Corporation Information
    Table 121. Sucampo Pharmaceuticals Description and Business Overview
    Table 122. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 124. Sucampo Pharmaceuticals Recent Developments/Updates
    Table 125. Ironwood Pharmaceuticals Corporation Information
    Table 126. Ironwood Pharmaceuticals Description and Business Overview
    Table 127. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 129. Ironwood Pharmaceuticals Recent Developments/Updates
    Table 130. Progenics Pharmaceuticals Corporation Information
    Table 131. Progenics Pharmaceuticals Description and Business Overview
    Table 132. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product
    Table 134. Progenics Pharmaceuticals Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Chronic Idiopathic Constipation (CIC) Drugs Distributors List
    Table 138. Chronic Idiopathic Constipation (CIC) Drugs Customers List
    Table 139. Chronic Idiopathic Constipation (CIC) Drugs Market Trends
    Table 140. Chronic Idiopathic Constipation (CIC) Drugs Market Drivers
    Table 141. Chronic Idiopathic Constipation (CIC) Drugs Market Challenges
    Table 142. Chronic Idiopathic Constipation (CIC) Drugs Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Chronic Idiopathic Constipation (CIC) Drugs
    Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2022 & 2029
    Figure 4. Lubiprostone Product Picture
    Figure 5. Linaclotide Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Chronic Idiopathic Constipation (CIC) Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2022 & 2029
    Figure 9. Hospitals & Clinics
    Figure 10. Ambulatory Surgical Centres
    Figure 11. Long Term Care Centres
    Figure 12. Others
    Figure 13. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (2018-2029) & (US$ Million)
    Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Sales (2018-2029) & (K Units)
    Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Average Price (USD/Unit) & (2018-2029)
    Figure 17. Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered
    Figure 18. Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturers in 2022
    Figure 19. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers in 2022
    Figure 20. The Global 5 and 10 Largest Chronic Idiopathic Constipation (CIC) Drugs Players: Market Share by Revenue in 2022
    Figure 21. Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 22. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 23. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2018-2029)
    Figure 24. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2018-2029)
    Figure 25. U.S. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Canada Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2018-2029)
    Figure 28. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2018-2029)
    Figure 29. Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. France Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. U.K. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Russia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2018-2029)
    Figure 35. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2018-2029)
    Figure 36. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. South Korea Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. India Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Australia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Thailand Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Philippines Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2018-2029)
    Figure 47. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2018-2029)
    Figure 48. Mexico Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Argentina Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2018-2029)
    Figure 52. Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2018-2029)
    Figure 53. Turkey Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Global Sales Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Type (2018-2029)
    Figure 57. Global Revenue Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Type (2018-2029)
    Figure 58. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Type (2018-2029)
    Figure 59. Global Sales Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Application (2018-2029)
    Figure 60. Global Revenue Market Share of Chronic Idiopathic Constipation (CIC) Drugs by Application (2018-2029)
    Figure 61. Global Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Application (2018-2029)
    Figure 62. Chronic Idiopathic Constipation (CIC) Drugs Value Chain
    Figure 63. Chronic Idiopathic Constipation (CIC) Drugs Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals
Frequently Asked Questions
Chronic Idiopathic Constipation (CIC) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Idiopathic Constipation (CIC) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Idiopathic Constipation (CIC) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Epigenomic

This report aims to provide a comprehensive presentation of the global market for Epigenomic, wit ... Read More